Annual Total Liabilities
$37.81 M
+$8.45 M+28.80%
31 December 2023
Summary:
Keros Therapeutics annual total liabilities is currently $37.81 million, with the most recent change of +$8.45 million (+28.80%) on 31 December 2023. During the last 3 years, it has risen by +$30.09 million (+389.67%). KROS annual total liabilities is now at all-time high.KROS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$46.44 M
+$12.33 M+36.15%
30 September 2024
Summary:
Keros Therapeutics quarterly total liabilities is currently $46.44 million, with the most recent change of +$12.33 million (+36.15%) on 30 September 2024. Over the past year, it has increased by +$16.03 million (+52.72%). KROS quarterly total liabilities is now at all-time high.KROS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.8% | +52.7% |
| 3 y3 years | +389.7% | +304.4% |
| 5 y5 years | +158.0% | - |
KROS Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +389.7% | at high | +304.4% |
| 5 y | 5 years | at high | +389.7% | at high | +520.1% |
| alltime | all time | at high | +389.7% | at high | +520.1% |
Keros Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $46.44 M(+36.2%) |
| June 2024 | - | $34.11 M(+7.0%) |
| Mar 2024 | - | $31.87 M(-15.7%) |
| Dec 2023 | $37.81 M(+28.8%) | $37.81 M(+24.4%) |
| Sept 2023 | - | $30.41 M(+1.2%) |
| June 2023 | - | $30.05 M(+2.0%) |
| Mar 2023 | - | $29.45 M(+0.3%) |
| Dec 2022 | $29.36 M | $29.36 M(+154.7%) |
| Sept 2022 | - | $11.53 M(-25.4%) |
| June 2022 | - | $15.45 M(+32.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $11.65 M(-3.6%) |
| Dec 2021 | $12.08 M(+56.4%) | $12.08 M(+5.2%) |
| Sept 2021 | - | $11.48 M(+47.1%) |
| June 2021 | - | $7.80 M(-16.6%) |
| Mar 2021 | - | $9.36 M(+21.2%) |
| Dec 2020 | $7.72 M(-26.2%) | $7.72 M(+3.1%) |
| Sept 2020 | - | $7.49 M(-17.5%) |
| June 2020 | - | $9.08 M(-6.8%) |
| Mar 2020 | - | $9.74 M(-6.9%) |
| Dec 2019 | $10.46 M(-28.6%) | $10.46 M |
| Dec 2018 | $14.65 M | - |
FAQ
- What is Keros Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Keros Therapeutics?
- What is Keros Therapeutics annual total liabilities year-on-year change?
- What is Keros Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Keros Therapeutics?
- What is Keros Therapeutics quarterly total liabilities year-on-year change?
What is Keros Therapeutics annual total liabilities?
The current annual total liabilities of KROS is $37.81 M
What is the all time high annual total liabilities for Keros Therapeutics?
Keros Therapeutics all-time high annual total liabilities is $37.81 M
What is Keros Therapeutics annual total liabilities year-on-year change?
Over the past year, KROS annual total liabilities has changed by +$8.45 M (+28.80%)
What is Keros Therapeutics quarterly total liabilities?
The current quarterly total liabilities of KROS is $46.44 M
What is the all time high quarterly total liabilities for Keros Therapeutics?
Keros Therapeutics all-time high quarterly total liabilities is $46.44 M
What is Keros Therapeutics quarterly total liabilities year-on-year change?
Over the past year, KROS quarterly total liabilities has changed by +$16.03 M (+52.72%)